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Uropathogenic Escherichia coli (UPEC) is the primary cause of urinary tract infection (UTI) in the developed world. The major
factors associated with virulence of UPEC are fimbrial adhesins, which mediate specific attachment to host receptors and trigger
innate host responses. Another group of adhesins is represented by the autotransporter (AT) subgroup of proteins. The genome-
sequenced prototype UPEC strain CFT073 contains 11 putative AT-encoding genes. In this study, we have performed a detailed
molecular characterization of two closely related AT adhesins from CFT073: UpaB (c0426) and UpaC (c0478). PCR screening
revealed that the upaB and upaC AT-encoding genes are common in E. coli. The upaB and upaC genes were cloned and charac-
terized in a recombinant E. coli K-12 strain background. This revealed that they encode proteins located at the cell surface but
possess different functional properties: UpaBmediates adherence to several ECM proteins, while UpaC expression is associated
with increased biofilm formation. In CFT073, upaB is expressed while upaC is transcriptionally repressed by the global regulator
H-NS. In competitive colonization experiments employing the mouse UTI model, CFT073 significantly outcompeted its upaB
(but not upaC) isogenic mutant strain in the bladder. This attenuated phenotype was also observed in single-challenge experi-
ments, where deletion of the upaB gene in CFT073 significantly reduced early colonization of the bladder.
Urinary tract infections (UTIs) are among the most frequenthuman bacterial infections, with an estimated 40 to 50% of
women experiencing at least one cystitis episode in their lifetime
(19, 34). UTI usually starts as a bladder infection (cystitis) but can
develop to acute kidney infection (pyelonephritis), ultimately re-
sulting in scaring and renal failure. UTI is also a major cause of
sepsis, which has a mortality rate of 25% and results in more than
36,000 deaths per year in the United States (66). Almost all pa-
tients with an indwelling urinary catheter for 30 days or longer
develop catheter-associated UTI, which accounts for approxi-
mately 40% of all hospital-acquired infections (19).
Uropathogenic Escherichia coli (UPEC) is the most common
etiological agent responsible for UTI, resulting in more than 80%
of infections. UPEC strains possess an array of virulence factors,
with no factor solely responsible for the ability to cause UTI (49).
However, the ability of UPEC to colonize the urinary tract and
cause disease involves the expression of adhesins (e.g., type 1 and
P fimbriae), toxins (e.g., hemolysin), and iron acquisition systems
that utilize siderophores (e.g., enterobactin, salmochelin, aero-
bactin) (36, 78). Adherence to the urinary tract epithelium enables
bacteria to resist the hydrodynamic forces of urine flow, to trigger
host and bacterial cell signaling pathways, and to establish infec-
tion. Among adhesins, P and type 1 fimbriae correlate strongly
with uropathogenesis and mediate binding to specific receptors
within the urinary tract (11, 46, 53, 67, 79, 80). Both P and type 1
fimbriae recognize their receptor targets by virtue of organelle
tip-located adhesins, PapG and FimH, respectively (31, 38). Re-
cent work employing a rat infection model has also demonstrated
that P and type 1 fimbriae can act in synergy to establish an infec-
tion that leads to nephron obstruction within the kidneys (42).
In addition to fimbrial adhesins, a number of autotransporter
(AT) proteins associated with virulence have been characterized
from UPEC. These include the secreted toxin Sat (21, 22), the
phase variable outer membrane protein antigen 43 (Ag43) (69),
the trimeric AT proteinUpaG (72), and the surface-locatedUpaH
(1). AT proteins represent the largest group of bacterial type V
secreted proteins and share several common features: an
N-terminal signal sequence, a passenger () domain that is either
anchored to the cell surface or released into the external milieu,
and a translocation () domain that resides in the outer mem-
brane (27, 32). AT proteins were originally thought to possess
structural properties that facilitate their independent transport
across the bacterial membrane system and final routing to the cell
surface (28). However, this classical view has recently been called
into question, as accessory factors, such as the Bam complex (also
known as the YaeT or Omp85 complex), as well as periplasmic
chaperones, such as SurA, Skp, and DegP, are required for the
secretion of some AT proteins (30, 51, 56, 57, 59, 74). In general,
AT proteins differ substantially in their passenger domain se-
quence, which determines the unique functional characteristics of
the protein and is often associated with virulence (28).
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Eleven putative AT-encoding genes have been identified in the
sequenced genome of the prototype UPEC strain CFT073 (1, 50).
The biological significance of these AT proteins and their roles in
UPECpathogenesis remain to be fully elucidated. In this study, we
have performed a detailed molecular characterization of two of
these AIDA-I-type conventional AT proteins, namely, UpaB
(c0426) and UpaC (c0478). The upaB and upaC genes were
cloned, and expression of UpaC significantly increased biofilm
formation in a recombinant strain. Using Western blot analysis,
we showed that UpaB (but not UpaC) is expressed by CFT073.
UpaC was shown to be transcriptionally repressed by the global
regulatorH-NS, andmutation of the hns gene relieved this repres-
sion. In themouse UTImodel, deletion of upaB (but not upaC) in
CFT073 significantly reduced early colonization of the bladder.
MATERIALS AND METHODS
Bacterial strains and growth conditions. The strains and plasmids used
in this study are listed in Table 1. Cells were routinely grown at 28°C or
37°C on solid or in liquid lysogeny broth (LB) medium (7) supplemented
with the appropriate antibiotics, kanamycin (Kan; 50 g/ml), chloram-
phenicol (Cam; 25 g/ml), ampicillin (Amp; 100 g/ml), spectinomycin
(Spec; 50 g/ml), and zeocin (Zeo; 50 g/ml). For growth in defined
conditions, M9 and M63B1 glucose media (58) were used as indicated.
Bacterial cultures for mouse experiments were prepared by overnight
growth in LB broth; all strains displayed an equivalent level of type 1
fimbriae expression as assessed by yeast cell agglutination.
DNA manipulations and genetic techniques. DNA techniques were
performed as described by Sambrook and Russell (58). Isolation of plas-
mid DNA was carried out using the QIAprep spin miniprep kit (Qiagen).
Restriction endonucleases were used according to the manufacturer’s
specifications (New England BioLabs). Chromosomal DNA purification
was made using the DNeasy blood and tissue kit (Qiagen). Oligonucleo-
tides were purchased fromSigma, Australia, or France. All PCRs requiring
proofreading were performed with the Expand high-fidelity polymerase
system (Roche) as described by the manufacturer. Amplified products
were sequenced to ensure fidelity of the PCR. DNA sequencing was per-
formed using the ABI BigDye version 3.1 kit (ABI) by the Australian
Equine Genetics Research Centre, University of Queensland, Brisbane.
Prevalence studies for the upaB and upaC genes used TaqDNA polymer-
ase, as described by the manufacturer (New England BioLabs), with the
primers c0426.s-5 (5=-GGAAAGGCAAAGTTTCAGGG) and c0426.s-3
(5=-GGTGGTATGTTTCTGTTTAC) or c0478.s-5 (5=-GGTGGTTGGGT
AGATGC) and c0478.s-3 (5=-GTTCACATCCAGTACACCAC).
Construction of plasmids with AT-encoding genes. The upaB and
upaC genes were amplified by PCR from UPEC CFT073 using specific
primers designed from the available genome sequence. The following
primers were used: for upaB (c0426), P1 (5=-CGCGCTCGAGATAATAA
GGAATGGGAAATTGAAATTAGTTAC) and P2 (5=-CGGCGAAGCTT
TTACCAGGTCACATTGATAC); and for upaC (c0478), P3 (5=-CGCGC
TCGAGATAATAAGGATGACAAATGCACTCCTG) and P4 (5=-CGGC
GGAATTCTTACCAGGTATATTTAACAC). PCR products containing
upaB and upaC were digested with XhoI (forward primer) and HindIII/
EcoRI (reverse primer) and ligated to XhoI-HindIII/EcoRI-digested plas-
mid pBAD/Myc-HisA. The resultant plasmids were then digested with
HindIII (upaB plasmid) or EcoRI (upaC plasmid) and ligated with a cor-
respondingly digested kanamycin resistance-encoding gene cassette to
give rise to plasmids pUpaB (pOMS14) and pUpaC (pOMS12). Resis-
tance to kanamycinwas required to facilitate transformation of these plas-
mids into the flu-negative, gfp-positive E. coli K-12 strain OS56. In all
constructs, expression of the AT-encoding gene is under the control of the
arabinose-inducible araBAD promoter (23). Neither of the genes was
cloned as fusions to the 6His-encoding sequence of the expression plas-
mid. Plasmids were verified by sequence analysis. The hns gene (c1701)
was subcloned from pBAD30c1701 (37) via digestion with NheI/SphI and
ligated to NheI/SphI-digested pBR322, creating pH-NS.
Construction of deletion and overexpression mutants. In order to
interrupt the AT-encoding genes in CFT073, create lacZ reporter tran-
scriptional fusions, andplace chromosomal target genes under the control
of the RExBAD promoter or PcL promoter (13, 14, 55), we used homol-
ogous recombinationmediated by -red recombinase expressed from the
pKOBEG plasmid (15) and either a one-step PCR procedure with 40-bp
homology arms for recombination or a three-step PCR procedure with
500-bp homology arms for recombination (15) (http://www.pasteur.fr
/recherche/unites/Ggb/matmet.html). All mutants were confirmed via
PCR and sequencing using primers Gene.ext 5= and Gene.ext 3=, either as
a primer set or individually in combination with internal primers de-
signed to bind within the inserted DNA fragments. The full list of primers
is available at http://www.pasteur.fr/recherche/unites/Ggb/submat.html.
CFT073lacI-Z upaC::lacZ-zeo mutants were screened after mutagenesis
with the suicide plasmid pSC189, carrying the kanamycin-resistant Mar-
iner transposon described previously (10, 12). Sequencing out from the
transposon in both directions enabled the site of insertion to be identified.
Purification of 6His-tagged UpaB and UpaC truncated proteins,
antibody production, and immunoblotting. A 1,219-bp segment from
the passenger-encoding domain ofupaBwas amplified byPCRwith prim-
ers UpaBTF (5=-TACTTCCAATCCAATGCCACGGTATCAACTGATC
CGG) and UpaBTR (5=-TTATGCACTTCCAATGTTATGTGGCTTTTA
GAGTGCTGTC) from E. coli CFT073 genomic DNA (underlined
nucleotides represent the ligation-independent cloning [LIC] overhangs
used for insertion into plasmid pMCSG7 via LIC cloning) (16). The re-
sultant plasmid (pUpaBTruncated) contained the base pairs 102 to 1,320
of upaB fused to a 6His-encoding sequence. E. coli BL21 was trans-
formed with plasmid pUpaBTruncated and induced with IPTG
(isopropyl--D-thiogalactopyranoside), and the resultant 6His-tagged
UpaB truncated protein (containing amino acids 35 to 440 of UpaB) was
assessed by SDS-PAGE analysis as previously described (70). Polyclonal
anti-UpaB serum was raised in rabbits by the Institute of Medical and
Veterinary Sciences (South Australia). A polyclonal antibody raised
against the enterohemorrhagic E. coli homologue of UpaC, EhaB, cross-
reacted with UpaC and was used for UpaC detection (75). It is referred in
this report as anti-UpaC antiserum. For immunoblotting, whole-cell ly-
sates were subjected to SDS-PAGE using NuPAGE Novex 4 to 12% Bis-
Tris precast gels with NuPAGE MES (morpholineethanesulfonic acid)
running buffer and subsequently transferred to polyvinylidene difluoride
(PVDF) microporous membrane filters using the iBlot dry-blotting sys-
tem as described by the manufacturer (Invitrogen). UpaB or UpaC anti-
serum, respectively, was used as the primary serum, and the secondary
antibody was alkaline phosphatase-conjugated anti-rabbit IgG. Sigma
Fast BCIP/NBT was used as the substrate in the detection process.
Biofilm assays. Biofilm formation on polystyrene surfaces was moni-
tored by using 96-well microtiter plates (IWAKI) essentially as previously
described (63). Briefly, cells were grown for 24 h in LB (containing 0.2%
arabinose for induction ofAT-encoding genes) at 37°C,washed to remove
unbound cells, and stained with crystal violet. Quantification of bound
cells was performed by the addition of acetone-ethanol (20:80) and the
measurement of the dissolved crystal violet at an optical density of 570 nm
(OD570). Flow chamber experiments were performed as previously de-
scribed (35, 62). Briefly, biofilms were allowed to form on glass surfaces in
a multichannel flow system that permitted online monitoring of their
structural characteristics. Flow cells were inoculated with standardized
cultures (OD600  0.02) pregrown overnight in M9 medium containing
arabinose and kanamycin. Biofilm development was monitored by con-
focal scanning laser microscopy at 15 h postinoculation. For analysis of
flow cell biofilms, z-stacks were analyzed using COMSTAT software pro-
gram (29). Microfermentor experiments were performed as previously
described (5, 20). Briefly, overnight cultures were grown in M63B1-0.4%
glucose medium in the presence and absence of 0.2% arabinose at 37°C.
Inoculation was performed by dipping the removable spatula in a culture
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TABLE 1 Bacterial strains and plasmids used in this study
Strain or plasmid Relevant characteristic(s) Reference
E. coli K12 strains
MS427 MG1655flu 52
OS56 MG1655flu attB::bla-gfp GFP, Ampr 64
MS427(pBAD) MS427 pBADMycHisA, Ampr 76
MS427(pUpaC) pUpaC in MS427, Ampr This study
MS427(pUpaB) pUpaB in MS427, Ampr This study
OS56(pBAD) OS56 pBADMycHisA 76
OS56(pUpaC) pUpaC in OS56, Ampr Kanr This study
OS56(pUpaB) pUpaB in OS56, Ampr Kanr This study
BL21 F ompT hsdS(rBmB) dcm gal Stratagene
MS2930 BL21 pUpaBTruncated This study
S17-1pir RP4-2Tc::mu kan::Tn7 pir; Pir-dependent replication, Mur Kanr 65
S17-1pir_pSC189 pSC189 in S17-1pir, Ampr Kanr 12
E. coli CFT073 strains
CFT073 Wild-type UPEC isolate 44
CFT073ara CFT073 araDAB::zeo, Zeor This study
CFT073amp CFT073 attB::amp-cfp, Ampr 18
RExUpaB CFT073ara camRExBADupaB, Zeor Camr, arabinose inducible UpaB This study
RExUpaC CFT073ara specRExBADupaC, Zeor Specr, arabinose inducible UpaC This study
CFT073upaB CFT073upaB::zeo, Zeor This study
CFT073upaC CFT073upaC::kan, Kanr This study
CFT073PcLupaB CFT073 kanPcLupaB, constitutively expressed UpaB, Kanr This study
CFT073PcLupaC CFT073 kanPcLupaC, constitutively expressed UpaC, Kanr This study
CFT073lacIZ CFT073lacIZ::cam, Camr This study
CFT073lacIZ upaB::lacZ-zeo CFT073lacIZ::cam upaB::lacZ-zeo, Camr Zeor This study
CFT073lacIZ upaB::lacZ-zeo c1701::kan CFT073lacIZ::cam upaB::lacZ-zeo c1701::kan, Camr Zeor Kanr This study
CFT073lacIZ upaB::lacZ-zeo c1701::kan pBR322 CFT073lacIZ::cam upaB::lacZ-zeo c1701::kan pBR322, Camr Zeor Kanr Ampr This study
CFT073lacIZ upaB::lacZ-zeo c1701::kan pH-NS CFT073lacIZ::cam upaB::lacZ-zeo c1701::kan pH-NS, Camr Zeor Kanr Ampr This study
CFT073lacIZ upaC::lacZ-zeo CFT073lacIZ::cam upaC::lacZ-zeo, Camr Zeor This study
CFT073lacIZ upaC::lacZ-zeo c1701::kan CFT073lacIZ::cam upaC::lacZ-zeo c1701::kan, Camr Zeor Kanr This study
CFT073lacIZ upaC::lacZ-zeo c1701::kan pBR322 CFT073lacIZ::cam upaC::lacZ-zeo c1701::kan pBR322, Camr Zeor Kanr Ampr This study
CFT073lacIZ upaC::lacZ-zeo c1701::kan pH-NS CFT073lacIZ::cam upaC::lacZ-zeo c1701::kan p-NS, Camr Zeor Kanr Ampr This study
CFT073lacIZ upaB::lacZ-zeo c0421::kan CFT073lacIZ::cam upaB::lacZ-zeo c0421::kan, Camr Zeor Kanr This study
CFT073lacIZ upaC::lacZ-zeo c0421::kan CFT073lacIZ::cam upaC::lacZ-zeo c0421::kan, Camr Zeor Kanr This study
CFT073lacIZ upaB::lacZ-zeo c1699::kan CFT073lacIZ::cam upaB::lacZ-zeo c1699::kan, Camr Zeor Kanr This study
CFT073lacIZ upaC::lacZ-zeo c1699::kan CFT073lacIZ::cam upaC::lacZ-zeo c1699::kan, Camr Zeor Kanr This study
CFT073lacIZ upaB::lacZ-zeo c2091::kan CFT073lacIZ::cam upaB::lacZ-zeo c2091::kan, Camr Zeor Kanr This study
CFT073lacIZ upaC::lacZ-zeo c2091::kan CFT073lacIZ::cam upaC::lacZ-zeo c2091::kan, Camr Zeor Kanr This study
CFT073lacIZ upaB::lacZ-zeo c2411::kan CFT073lacIZ::cam upaB::lacZ-zeo c2411::kan, Camr Zeor Kanr This study
CFT073lacIZ upaC::lacZ-zeo c2411::kan CFT073lacIZ::cam upaC::lacZ-zeo c2411::kan, Camr Zeor Kanr This study
CFT073lacIZ upaB::lacZ-zeo c3218::kan CFT073lacIZ::cam upaB::lacZ-zeo c3218::kan, Camr Zeor Kanr This study
CFT073lacIZ upaC::lacZ-zeo c3218::kan CFT073lacIZ::cam upaC::lacZ-zeo c3218::kan, Camr Zeor Kanr This study
CFT073lacIZ upaB::lacZ-zeo c3244::kan CFT073lacIZ::cam upaB::lacZ-zeo c3244::kan, Camr Zeor Kanr This study
CFT073lacIZ upaC::lacZ-zeo c3244::kan CFT073lacIZ::cam upaC::lacZ-zeo c3244::kan, Camr Zeor Kanr This study
CFT073lacIZ upaB::lacZ-zeo c3744::kan CFT073lacIZ::cam upaB::lacZ-zeo c3744::kan, Camr Zeor Kanr This study
CFT073lacIZ upaC::lacZ-zeo c3744::kan CFT073lacIZ::cam upaC::lacZ-zeo c3744::kan, Camr Zeor Kanr This study
CFT073lacIZ upaB::lacZ-zeo c4864::kan CFT073lacIZ::cam upaB::lacZ-zeo c4864::kan, Camr Zeor Kanr This study
CFT073lacIZ upaC::lacZ-zeo c4864::kan CFT073lacIZ::cam upaC::lacZ-zeo c4864::kan, Camr Zeor Kanr This study
CFT073lacIZ upaB::lacZ-zeo c5054::kan CFT073lacIZ::cam upaB::lacZ-zeo c5054::kan, Camr Zeor Kanr This study
CFT073lacIZ upaC::lacZ-zeo c5054::kan CFT073lacIZ::cam upaC::lacZ-zeo c5054::kan, Camr Zeor Kanr This study
Plasmids
pUpaB (pOMS14) upaB gene (c0426) from CFT073 in pBAD/Myc-HisA-kan, Ampr Kanr This study
pUpaC (pOMS12) upaC gene (c0478) from CFT073 in pBAD/Myc-HisA-kan, Ampr Kanr This study
pBAD30c1701 H-NS c1701 (H-NS) from CFT073 in pBAD30, Ampr 37
pBR322 Ampr Tetr 8
pH-NS pBR322 c1701 (H-NS) from CFT073, Ampr This study
pKOBEG pSC101 ts (replicates at 30°C), araC, arabinose-inducible red operon, Camr 9
pSC189 oriT,-dependent oriR6K,mariner-based transposon TnSC189, Ampr Kanr 10
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containing 108 bacteria/ml for 2 min, followed by reintroduction of the
spatula into themicrofermentor. TheM63B1-0.4% glucose medium flow
was set at the constant rate of 0.75 ml/min. After 24 h, the biofilm formed
on the spatula was resuspended in 10 ml of phosphate-buffered saline
(PBS) and the optical density at 600 nm was measured for each suspen-
sion; these values directly reflect the biofilm biomass. All experiments
were performed in triplicate.
ECMprotein binding assays.Bacterial binding to extracellularmatrix
(ECM) proteins was performed in a microtiter plate enzyme-linked im-
munosorbent assay (ELISA) essentially as previously described (72). Mi-
crotiter plates (Maxisorp; Nunc) were coated overnight at 4°C with Max-
Gel human extracellular matrix (10 g/ml) or with 2 g of the following
ECM proteins, respectively: collagen (types I to V), fibronectin, fibrino-
gen, laminin, elastin, heparin sulfate, human serum album, bovine serum
albumin (BSA) (Sigma-Aldrich), or the glycansN-acetyl-D-galactosamine
(NaGal), N-acetyl-D-glucosamine (NaGlu), or N-acetylneuraminic acid
(NaNa). Wells were washed twice with TBS (137 mMNaCl, 10 mM Tris,
pH 7.4) and then blocked with TBS-2% milk for 1 h. After being washed
with TBS, 200 l of washed and standardized (OD600  0.1)
MS427(pUpaB), MS427(pUpaC), or MS427(pBAD) was added, and the
plates were incubated at 37°C for 2 h. After being washed to remove
nonadherent bacteria, adherent cells were fixed with 4% paraformalde-
hyde, washed, and incubated for 1 hwith anti-E. coli serum (Meridian Life
Sciences Inc.; catalog number B65001R) diluted 1:500 in 0.05% TBS-
Tween and 0.2% milk, washed, and incubated for 1 h with a secondary
anti-rabbit-conjugated horseradish peroxidase antibody (diluted 1:1,000)
(Sigma-Aldrich; catalog number A6154). After a final wash, adhered bac-
teriawere detected by adding 150l of 0.3mg/mlABTS [2,2=-azino-bis(3-
ethylbenzthiazoline-6-sulfonic acid)] (Sigma-Aldrich) in 0.1 M citric
acid, pH 4.3, activated with 1 l/ml 30% hydrogen peroxide, and the
absorbance was read at 405 nm. Mean absorbance readings were com-
pared with negative-control readings ofMS427(pBAD) using two-sample
t tests within the Minitab V14 software package. P values of 0.05 were
considered significant.
Microscopy and image analysis. UpaB or UpaC antiserum was used
for immunofluorescence microscopy and immunogold electron micros-
copy as previously described (68, 72).Microscopic observation of biofilms
and image acquisition were performed on a confocal laser-scanning mi-
croscope (LSM510 META; Zeiss) equipped with detectors and filters for
monitoring of green fluorescent protein (GFP). Vertical cross sections
through the biofilms were visualized using the Zeiss LSM Image Exam-
iner. Images were further processed for display by using Photoshop soft-
ware (Adobe, Mountain View, CA).
-Galactosidase assays. -Galactosidase assays were performed es-
sentially as previously described (43). Briefly, strains carrying lacZ fusions
were grown on LB plates for 16 h and then inoculated into LB medium.
After 16 to 18 h of growth, the culture was diluted in Z buffer (60 mM
Na2HPO4, 40 mMNaH2PO4, 50 mM -mercaptoethanol, 10 mM KCl, 1
mM MgSO4, pH 7), 0.004% SDS and chloroform were added, and the
samples were vortexed to permeabilize the cells. Samples were incubated
at 28°C, and the reaction was initiated by the addition of ONPG
(o-nitrophenyl--D-galactopyranoside). Reactions were stopped with the
addition of sodiumbicarbonate, and the enzymatic activity was assayed in
quadruplicate for each strain by measuring the absorbance at 420 nm. In
some cases, -galactosidase activity was also observed on LB agar plates
containing 5-bromo-4-chloro-3-indolyl--D-galactoside (X-Gal).
DNA curvature prediction and electrophoretic mobility shift as-
says. The upaC promoter region was analyzed in silico using bend.it, a
program that enables the prediction of a curvature propensity plot calcu-
lated with DNase I-based parameters (http://hydra.icgeb.trieste.it/dna/)
(73). The curvature is calculated as a vector sum of dinucleotide geome-
tries (roll, tilt, and twist angles) and expressed as degrees per helical turn
(10.5°/helical turn 1°/bp). Experimentally tested curvedmotifs produce
curvature values of 5 to 25°/helical turn, whereas straight motifs give val-
ues below 5°/helical turn. The upaC 250-bp promoter region was ampli-
fied using primers upaC.pro.ext-5250 and upaC.pro.ext-3-1ATG, and
its intrinsic curvature was assessed by comparing its electrophoretic mo-
bility with that of an unbent marker fragment (Promega; 100-bp DNA
ladder) on a 0.5% Tris-borate-EDTA (TBE), 7.5% PAGE gel at 4°C for
retarded gel electrophoretic mobility.
Gel shift assays were performed essentially as previously described (3).
A DNA mixture comprising an equimolar ratio of the PCR-amplified
upaC promoter region and TaqI-SspI-digested pBR322 was incubated at
room temperature for 15 min with increasing amounts of native purified
H-NS protein (a gift from S. Rimsky) in 30 l of reaction mixture con-
taining 40 mMHEPES (pH 8), 60 mM potassium glutamate, 8 mMmag-
nesium aspartate, 5mMdithiothreitol, 10% glycerol, 0.1%octylphenoxy-
polyethoxyethanol, 0.1 mg/ml BSA (H-NS binding buffer). DNA
fragments and DNA-protein complexes were resolved by gel electropho-
resis (0.5%TBE, 3%MSagarose gel run at 50V at 4°C) and visualized after
staining with ethidium bromide.
Mouse model of UTI. Female C57BL/6 mice (8 to 10 weeks) were
purchased from theUniversity of QueenslandAnimal Facility and housed
in sterile cages with ad libitum access to sterile water. Themousemodel of
UTI described previously was used for this study (54). Briefly, an inocu-
lum of 20l, containing 5 108 CFU of bacteria in PBS (containing 0.1%
India ink) was instilled directly into the bladder using a 1-ml tuberculin
syringe attached to a catheter. Groups ofmice were euthanized at 18 h and
5 days after challenge by cervical dislocation; bladders were then excised
aseptically, weighed, and homogenized in PBS. Bladder homogenates
were serially diluted in PBS and plated onto LB agar for colony counts.
Competitive mixed-infection assays were performed as described above
except that mice were inoculated with a 50:50 mixture of CFT073amp and
CFT073upaB or CFT073upaC grown in the absence of antibiotics. The
two strains were differentiated by their resistance to ampicillin
(CFT073amp) and zeocin (CFT073upaB) or kanamycin (CFT073upaC) to
enable differential colony counts of the recovered bacteria. The output
ratios were normalized to the input ratios to determine the competitive
index ([mutant ouput/wild-type ouput]/[mutant input/wild-type in-
put]). For competitive infections, significance was determined using the
Wilcoxon rank-sum test on log10-transformed fitness indices against a
hypothetical median of 0 (log101 0) using GraphPad Prism 5. For single
infections, the median numbers of bacterial CFU were compared using
the nonparametric Mann-Whitney test within the Minitab V14 software
package. P values of0.05 were considered significant.
Statistical analysis. The prevalences of the upaB and upaC genes in
uropathogenic and nonpathogenic E. coli strains were compared using
Fisher’s exact test.
RESULTS
Bioinformatic analysis of theUpaB andUpaCATproteins from
UPECCFT073. Eleven putativeAT-encoding genes have been iden-
tified in the sequencedgenomeof theprototypeUPECstrainCFT073
(1, 50). In order to investigate the functionality of UpaB and UpaC,
weperformedabioinformatic analysis of these hypothetical proteins.
Analysis of the 770-amino-acidUpaB and the 995-amino-acidUpaC
sequenceusing theConservedDomainDatabase (CDD) (40, 41) and
the Simple Modular Architecture Design Tool (SMART) (39) iden-
tified a pertactin-like passenger domain (cl00185) followed by anAT
-domain (cl002365) in the C-terminal region of both proteins. The
predicted-domain sequencebegins at aminoacid500 forUpaBand
aminoacid 725 forUpaC. Further analysiswith SignalP (6) identified
a characteristic signal peptide for both proteins (31 amino acids in
length for UpaB and 27 amino acids in length for UpaC). We also
detected sequence similarity to the pectin lyase-like superfamily
within the passenger () domain of UpaB and UpaC using Inter-
ProScan (82). The pectin lyase-like superfamily sequence has a
predominant secondary structure of right-handed parallel -helix
topology.
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Prevalence of the AT-encoding genes in UPEC. The preva-
lences of the upaB and upaC genes were assessed by PCR screening
of uropathogenic and nonpathogenic E. coli strains obtained from
both the ECOR collection (48) and our own laboratory collection.
The upaB and upaC genes are common among UPEC strains
(58% [21/36] and 47% [17/36], respectively) and nonpathogenic
E. coli strains (42% [26/62] and 34% [21/62], respectively). There
was no significant difference between the presence of the genes in
UPEC and nonpathogenic E. coli.
Cloning and expression of AT-encoding genes from UPEC
CFT073. The upaB (c0426) and upaC (c0478) genes were PCR
amplified and cloned as a transcriptional fusion downstream of
the tightly regulated araBAD promoter in the pBAD/Myc-HisA
expression vector to generate the plasmids pUpaB (pOMS14) and
pUpaC (pOMS12), respectively. To demonstrate expression of the
UpaB and UpaC proteins, plasmids pUpaB and pUpaC were
transformed into the E. coli K-12 flu mutant strains MS427 and
OS56, respectively.E. coliMS427 contains amutation in theAg43-
encoding flu gene and is unable to mediate cell aggregation and
biofilm formation (52), while OS56 is a derivative of MS427 that
has been tagged at the -attachment site with gfp (64). In the case
of UpaB, Western blot analysis using a UpaB-specific antiserum
resulted in the detection of a band corresponding to the full-
length UpaB protein (80.1 kDa) in whole-cell lysates prepared
from E. coli OS56(pUpaB) following induction with arabinose
(Fig. 1A). Likewise, in the case of UpaC, Western blot analysis
FIG 1 (A) Western blot analysis of UpaB and UpaC performed using whole-cell lysates prepared from E. coli grown in the presence of 0.2% arabinose. (i)
OS56(pUpaB), OS56(pBAD); (ii) OS56(pUpaC), OS56(pBAD). Lane M, Novex Sharp molecular weight marker. (B) Phase contrast (i), immunofluorescence
(ii), and immunogold electron microscopy (iii) using UpaB-specific antiserum against cells of E. coli strains MS427(pUpaB) and MS427(pBAD) or UpaC
antiserum against cells of E. coli strainsMS427(pUpaC) orMS427(pBAD). Cells were grown in the presence of 0.2% arabinose. Overnight cultures were fixed and
incubated with anti-UpaB or anti-UpaC serum, respectively, followed by incubation with goat anti-rabbit IgG coupled to Alexa Fluor 488 for immunofluores-
cence or protein A-gold (10 nm) conjugate. Gold particles were present on the surface of E. coli MS427(pUpaB) and MS427(pUpaC) but not on that of the
MS427(pBAD) control strain.
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using a UpaC antiserum resulted in the detection of a band of 120
kDa (slightly larger than the predicted 107-kDamolecularmass of
UpaC) in whole-cell lysates prepared from E. coli OS56 (pUpaC)
following induction with arabinose (Fig. 1A). No processing or
cleavage of the respective mature passenger and translocation do-
main from UpaB or UpaC was observed in whole-cell lysates or
following brief heat treatment of the cells at 60°C for 3 min (data
not shown).
UpaB and UpaC are located at the bacterial cell surface. To
examine if the UpaB and UpaC AT proteins were localized to the
outer membrane, immunofluorescence microscopy was per-
formed (Fig. 1B). UpaB and UpaC antiserum readily reacted with
E. coli MS427(pUpaB) and MS427(pUpaC), respectively, follow-
ing induction with arabinose during growth in LB broth. Thus,
UpaB and UpaC were effectively translocated to the cell surface.
No reaction was seen with E. coli MS427(pBAD) cells. Surface
localization ofUpaB andUpaCwas confirmedusing immunogold
labeling and electronmicroscopy (Fig. 1B). E. coliMS427(pUpaB)
and MS427(pUpaC) cells clearly displayed surface labeling with
gold particles following incubationwithUpaB orUpaC antiserum
compared to E. coliMS427(pBAD) cells. Thus, the upaB and upaC
genes are functional and encode proteins located at the cell surface
in E. coli.
Phenotypic properties of UpaB and UpaC. AT proteins are
frequently associated with aggregation, cell adherence, adhesion
to ECM proteins, and biofilm formation. The overexpression of
UpaB and UpaC in E. coli OS56 did not result in aggregation or
adherence to T24 epithelial cells, HeLa cells, or shed human uro-
epithelial cells. However, when we assessed the ability to form a
biofilm in a static, nontreated polystyrene microtiter plate model,
UpaC, but not UpaB, promoted biofilm formation after growth in
LB medium (t test, P 0.01) (Fig. 2A). Next, we tested the ability
of the AT proteins to promote biofilm formation in dynamic con-
ditions using the microfermentor and continuous flow chamber
model systems, the latter allowing us to monitor bacterial distri-
bution within an evolving biofilm at the single-cell level due to the
FIG 2 Biofilm formation by E. coliOS56 cells harboring plasmids expressing UpaB and UpaC. The effect of AT expression on biofilm formation was assessed in
E. coliOS56 (MG1655flu, Gfp) cells containing the following plasmids pBAD, pUpaB, or pUpaC. All strains were grown in the presence of 0.2% arabinose to
induce AT protein expression. Three assays were used: (A) static biofilm formation in polystyrene microtiter plates, (B) dynamic biofilm formation in a
microfermentor system, and (C) dynamic biofilm formation using a flow chamber model. In the dynamic-flow-chamber biofilm development was monitored
by confocal scanning lasermicroscopy after 15 h. The images are representative horizontal sections collectedwithin each biofilm and vertical sections (to the right
of and above each larger panel, representing the yzplane and the xzplane, respectively) at the positions indicated by the red and green lines.E. coliMS427(pUpaC)
produced a biofilm with a significant increase in total biovolume, substratum coverage and mean thickness compared to the vector control strain at 15 h
postinoculation (COMSTAT). In the microfermentor assay, UpaC also promoted significant biofilm growth compared to the vector control strain (unpaired t
test with Welch=s correction P 0.05).
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combination of gfp-tagged cells and confocal laser-scanning mi-
croscopy. UpaC promoted significant biofilm growth in both the
flow cell and microfermentor assays (unpaired t test withWelch’s
correction, P  0.05) (Fig. 2B and C). Thus, UpaC represents a
UPEC AT protein that promotes biofilm growth.
Next, we used an ELISA-based method to test the abilities of
UpaB andUpaC tomediate adherence toMaxGel, a commercially
available mixture of ECM components, including collagens,
laminin, fibronectin, tenascin, elastin, a number of proteoglycans,
and glycosaminoglycans. UpaB (but not UpaC) promoted signif-
icant binding toMaxGel (Fig. 3), and this prompted us to examine
binding in more detail by testing a range of different ECM pro-
teins. UpaB promoted binding to fibronectin, fibrinogen, and
laminin but not to BSA (negative control) (Fig. 3) or to collagen type
I, type II, type III, type IV, and typeV, elastin, heparin sulfate, human
serum album, or the glycans N-acetyl-D-galactosamine (NaGal),
N-acetyl-D-glucosamine (NaGlu), and N-acetylneuraminic acid
(NaNa) (data not shown). Therefore, UpaB represents a UPEC AT
protein that promotes specific binding to some ECMproteins.
The UpaB protein is expressed by CFT073. To determine
whether the UpaB and UpaC proteins are expressed by E. coli
CFT073, we constructed isogenic deletion mutants of upaB and
upaC, respectively, using -red-mediated homologous recombi-
nation of linear DNA (these mutants are referred to as
CFT073upaB and CFT073upaC, respectively). Examination of
whole-cell lysates prepared from these isogenic strains following
growth in LB broth by Western blotting showed expression of
UpaB (but not UpaC) in E. coli CFT073 (Fig. 4A). This was, how-
ever, not sufficient to allow detection of UpaB at the cell surface of
CFT073 by immunofluorescence (Fig. 5A). Nevertheless, comple-
mentation of CFT073upaBwith plasmid pUpaB restored the abil-
ity of this strain to produce detectable levels of UpaB at the cell
surface (Fig. 5A).Western blot analysis did not show expression of
UpaC from CFT073 (Fig. 4B). Accordingly, UpaC could not be
detected at the cell surface of CFT073 by immunofluorescence
(Fig. 5B). This was not caused by a defect in the stability of the
protein, as complementation of CFT073upaC with pUpaC re-
sulted in detection of UpaC (Fig. 5B). In addition, we detected
surface localization of both UpaB and UpaC in UpaB/UpaC over-
expression strains constructed by chromosomal insertion of
the inducible RExBAD expression cassette and a PR constitu-
tive promoter (13, 55) in front of each open reading frame,
respectively (CFT073RexBADupaB and CFT073RexBADupaC,
CFT073PcLupaB and CFT073PcLupaC) (Fig. 5).
The H-NS protein is a repressor of UpaC. To investigate the
genetic basis of repression of upaC and compare this to upaB, we
inserted an lacZ reporter as a transcriptional fusion to the promot-
ers of upaB and upaC on the chromosome of CFT073lacI-Z to
generate the CFT073lacI-Z upaB::lacZ-zeo and CFT073lacI-Z
upaC::lacZ-zeo strains. When grown on X-Gal plates, all
CFT073lacI-Z upaB::lacZ-zeo colonies were blue (indicating tran-
scription) and all CFT073lacI-Z upaC::lacZ-zeo colonies were very
faint blue (indicating very low levels of transcription). No color
heterogeneity was observed among the CFT073lacI-Z upaB::lacZ-
zeo and CFT073lacI-Z upaC::lacZ-zeo colonies, indicating that ex-
pression of UpaB and UpaC is not subjected to phase variation.
Subsequently, we created specific gene deletions by -red-
mediated homologous recombination in a panel of defined/puta-
tive E. coli CFT073 regulatory genes: c0421 (virF like), c1699
(rpoS), c1701 (hns), c2091 (virF like), c2411 (hns like), c3218
(stpA), c3244 (luxS AI-2), c3744 (virF like), c4864 (cpxR periplas-
mic stress), and c5054 (soxR oxidative stress) in CFT073lacI-Z
upaB::lacZ-zeo and CFT073lacI-Z upaC::lacZ-zeo strains. Each of
these mutants was then assayed for -galactosidase activity to as-
sess the effect of these regulators on transcription from the upaB
or upaC promoter (data not shown). No regulators of upaB were
identified (data not shown). However, H-NS was identified as a
repressor of upaC; the CFT073lacI-Z upaC::lacZ-zeo hns mutant
exhibited a 20-fold increase in -galactosidase activity compared
to that of the CFT073lacI-Z upaC::lacZ-zeo mutant (Fig. 4C). An
independent experiment employing randommariner transposon
mutagenesis resulted in the generation of six blue colonies, all of
which possessed significantly increased -galactosidase activity
due to the inactivation of hns and thus confirmed these observa-
tions (data not shown).We also complemented the CFT073lacI-Z
upaC::lacZ-zeo hns mutant with an hns-containing plasmid (pH-
NS), and this resulted in a significant reduction in the expression
of upaC (Fig. 4C). Thus, UpaC is repressed by H-NS.
The H-NS protein represses upaC transcription in CFT073.
To confirm the above-mentioned results, an hns isogenic mutant
was constructed in CFT073 and examined via Western blot anal-
ysis. Loss of H-NS from CFT073 resulted in the appearance of a
band representingUpaC,whichmigrated at the same size asUpaC
from OS56(pUpaC) (Fig. 1A). However, no expression of UpaC
was observed in a CFT073upaC hns double mutant (Fig. 4B). This
H-NS specific repression of UpaC was not observed for UpaB,
which was detected in wild-type CFT073 and a CFT073 hns mu-
tant (Fig. 4A). Taken together, these results demonstrate that
H-NS negatively regulates the expression of UpaC.
H-NS binds to the promoter region of upaC. H-NS binds to
intrinsically curved regions of DNA. An in silico-generated
curvature-propensity plot calculated with DNase I-based param-
eters suggested that the promoter region of upaC may adopt a
curved conformation (Fig. 4D). To experimentally demonstrate
this curvature, a 250-bp PCR product containing the predicted
upaC promoter region was generated and examined by polyacryl-
amide gel electrophoresis at 4°C. This method has been used pre-
viously to demonstrate DNA curvature (71, 81). Indeed, the
250-bp upaC promoter region displayed a slightly retarded gel
FIG 3 UpaB mediates attachment to a range of ECM proteins in an ELISA-
based binding assay. Black bars, E. coli MS427(pUpaB); hatched bars, E. coli
MS427(pUpaC); white bars, E. coliMS427(pBAD). Results represent averages
of results from 3 independent experiments  standard errors of the means
(SEM).Mean absorbance readingswere comparedwith negative-control read-
ings MS427(pBAD).
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electrophoretic mobility compared to that of noncurved DNA
standards (Fig. 4E). In order to investigate whether H-NS influ-
ences gene expression by direct binding to the curved promoter
region of upaC, we performed electrophoretic mobility shift as-
says. The 250-bpPCRproductwasmixedwithTaqI-SspI-digested
pBR322 DNA (which contains the bla promoter and has been
previously shown to be bound by H-NS) and was incubated with
increasing concentrations of purified H-NS protein and subse-
quently visualized by gel electrophoresis. The 250-bp upaC pro-
moter region and the fragment containing the bla promoter were
retarded in mobility by the addition of 0.5 M H-NS (Fig. 4F).
The pBR322 fragments not containing the bla promoter were not
influenced byH-NS at these concentrations, indicating that H-NS
bindswith specificity. These results suggest thatH-NS binds to the
regulatory region of upaC by recognizing a DNA region within
250 bp 5= of the ATG translation start codon.
Deletion of upaB from CFT073 reduces colonization of the
mouse bladder in amixed-infection competition assay.Toassess
the role of UpaB and UpaC on virulence, we examined the ability of
CFT073, CFT073upaB, and CFT073upaC to survive in competitive
colonization experiments. The strains had identical growth rates in
LB broth and did not display any difference with respect to type 1
fimbriae production (as assessed by yeast cell agglutination and an
fim switch orientation PCR) (data not shown). Mice were coinocu-
lated with CFT073 and CFT073upaB or CFT073 and CFT073upaC
strains in a 1:1 ratio. In this assay, CFT073upaB was significantly
outcompeted by CFT073 in the bladder of infectedmice (P 0.014)
(Fig. 6A). No difference in colonization was observed between
CFT073 and CFT073upaC (Fig. 6A).
Deletion of upaB from CFT073 reduces colonization of the
mouse bladder in single-infection experiments. To further as-
sess the role of UpaB on virulence, we examined the ability of
FIG 4 The H-NS protein is a repressor of UpaC. (A)Western blot analysis of UpaB using whole-cell lysates; (B)Western blot analysis of UpaC using whole-cell
lysates; (C) beta-galactosidase assay of upaB::lacZ-zeo and upaC::lacZ-zeo fusions; (D) curvature propensity plots showing predicted regions of curved DNA in
the 250-bp upaC promoter. (E) Curved DNA PAGE gel of the amplified 250-bp upaC promoter at 4°C. Migration of this band is slightly retarded in the gel,
suggesting that the DNA is curved. (F) Electrophoretic band shift of the amplified 250-bp upaC promoter and the bla promoter from digest pBR322 DNA. The
pBR322 fragments not containing the bla promoter were not influenced by the increasing concentrations of (0.05, 0.1, 0.2, 0.5, 1, and 2M)H-NS. Images depict
representative gels from at least two independent experiments.
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CFT073 and CFT073upaB to survive in themouse urinary tract in
single-infection experiments employing a short (1-day)- and long
(5-day)-term protocol. We observed a significant reduction in
colonization of the bladder by the CFT073upaB mutant (P 
0.001; Fig. 6B) at day 1 postinfection. However, by day 5 postin-
fection, equivalent bacterial loads were recovered for CFT073 and
CFT073upaB (Fig. 6C). No significant colonization of the kidneys
was observed for either strain; this is consistent with previous data
from our laboratory using C57BL/6 mice (68, 72).
DISCUSSION
UPEC strains produce a range of fimbrial and nonfimbrial ad-
hesins that play a role in virulence and contribute to persistent
infection of the urinary tract. Some UPEC fimbrial adhesins, in-
cluding type 1 and P fimbriae, have been well characterized with
respect to their expression, regulation, receptor-binding target,
and role in virulence. Of the nonfimbrial adhesins, the AT family
of proteins represents another group of virulence factors that con-
tribute to adhesion, invasion, and biofilm formation. Although
UPEC strains possess multiple AT-encoding genes, very little is
known about the function of their products and only Ag43,UpaG,
Sat, and UpaH have been associated with virulence (1, 21, 22, 69,
72). Here, we characterize the UpaB and UpaC AT proteins from
CFT073; we demonstrate that UpaB mediates binding to ECM
proteins and contributes to early colonization of the mouse blad-
der, while UpaC contributes to in vitro biofilm formation.
Eleven putative AT-encoding genes have been identified in the
sequenced genome of the prototype UPEC strain CFT073 (1, 50).
In this study, we cloned and characterized the upaB and upaC
AIDA-I-type AT-encoding genes from CFT073. The upaB gene is
present in all available UPEC genomes but absent or disrupted in
all diarrheagenic E. coli genomes (77), suggesting that it may con-
tribute to UPEC virulence. The upaC gene is disrupted in the
commensal E. coli strainsMG1655, DH1, andHS.While there was
no significant difference in the prevalence of the upaB and upaC
genes in UPEC and nonpathogenic E. coli, our data suggest that
their presence is associated with gene acquisition or loss mediated
by mobile genetic elements.
UpaB and UpaC both contain a predicted signal sequence, a
pertactin-like domain, and anAT-domain that is common to all
AT proteins. The passenger domain possesses sequence similarity
to the pectin lysase-like superfamily and contains an extensive
-sheet secondary structure as predicted by the fold recognition
program I-TASSER (83). It is therefore likely that the passenger
domain of UpaB and UpaC comprises a -helix structure akin to
that proposed for the majority of other AT proteins (33).
Several studies have demonstrated that the intimate cell-cell
FIG 5 (A) Phase-contrast (i) or immunofluorescence (ii) microscopy employing UpaB-specific antiserum against cells of E. coli strains as specified; (B)
phase-contrast (i) or immunofluorescence (ii) microscopy using UpaC antiserum against cells of E. coli strains as specified. Strains were grown in the presence
of 0.2% arabinose and labeled as induced where applicable. Overnight cultures were fixed and incubated with anti-UpaB or anti-UpaC serum followed by
incubation with goat anti-rabbit IgG coupled to Alexa Fluor 488. A positive reaction indicating surface localization of UpaB or UpaC was detected only for the
overexpressing strains.
Characterization of UpaB and UpaC, Two AT Proteins from UPEC
January 2012 Volume 80 Number 1 iai.asm.org 329
 o
n
 O
ctober 19, 2015 by University of Queensland Library
http://iai.asm
.org/
D
ow
nloaded from
 
contact required for AT adhesin interaction can be physically
blocked by the expression of larger surface structures, such as
fimbriae, flagella, lipopolysaccharide (LPS), and the capsule (4,
26, 60, 61, 64, 68, 70). Our strategy to study the function of UpaB
and UpaC involved the use of two host strains, MG1655flu and
UPEC CFT073. The MG1655flu strain (and its GFP-positive de-
rivative OS56) are well characterized and represent an ideal back-
ground to assess the function of AT adhesins (64). The surface
expression of UpaC (but not UpaB) in this background signifi-
cantly increased biofilm formation, while UpaB (but not UpaC)
mediated adherence to several ECM proteins, including fibronec-
tin, fibrinogen, and laminin. The lack of UpaC-mediated binding
to laminin was in contrast to the previously reported binding
characteristics of a closely related homologue, EhaB from entero-
hemorrhagic E. coli (EHEC) (75). Although EhaB andUpaC share
62.1% amino acid sequence identity and are detected with the
same polyclonal EhaB antiserum, the molecular basis for this dif-
ference in function remains to be elucidated.
Immunodetection of the UpaB and UpaC proteins revealed
that while UpaB could be detected in whole-cell extracts of
CFT073, the UpaC protein was not detected in whole-cell extracts
of CFT073 prepared under the same conditions. The difference
between the-galactosidase activitymeasured from the upaB lacZ
transcriptional fusion strain and the level of UpaB detected in
CFT073 byWestern blot analysismay be due tomRNA stability or
posttranscriptional factors that affect protein stability. H-NS is a
histone-like DNA binding protein that represses multiple viru-
lence factors in UPEC (45), and our results demonstrated that
H-NS also acts as a repressor of upaC transcription, most likely
throughdirect binding to its promoter region.H-NSwas shown to
bind to a region comprising the 250 bp upstreamof the upaC open
reading frame. Modulating the expression of the hns gene may
well be a mechanism evolved by UPEC and other E. coli strains to
control the expression of various virulence factors, including ad-
hesins. It is possible that the transcription of upaC is coordinated
with other H-NS repressed genes; for example, several cryptic E.
coli chaperone-usher fimbrial geneswere also recently shown to be
repressed byH-NS (37). In contrast toupaC, targetedmutagenesis
strategies did not indicate that the transcription of upaB is regu-
lated by H-NS.
While upaC expression was repressed in CFT073 during in
vitro growth, analysis of the data deposited in the Array Express
database examining the transcriptome of the asymptomatic uri-
nary tract colonizer E. coli 83972 identified upregulation of upaC
transcription during biofilm formation in human urine (25), sug-
gesting that UpaC is expressed under conditions similar to those
encountered in the urinary tract. Additionally, Hagan et al. re-
cently published the first transcriptome analysis for UPEC col-
lected from the urine of patients with symptomatic UTI and com-
pared this to the transcriptome of the same strains grown in vitro
(24). Analysis of the data deposited in the GEO series database
revealed that transcripts for upaB and upaCwere detected in some
UPEC strains, suggesting that these genes are transcribed during
human UTI. We observed a significant difference in bladder col-
onization between CFT073 and CFT073upaB in a competitive
mixed-infection assay and at day 1 postinfection in a single-
infection assay, strongly suggesting that expression of UpaB is
associated with early colonization of the mouse bladder. In con-
trast, we did not observe any difference between CFT073 and
CFT073upaB at day 5 postinfection.
FIG 6 Mouse UTI assays. (A) Competitive mixed-infection experiment em-
ploying a 1:1 mixture of E. coli CFT073amp/CFT073upaB and E. coli
CFT073amp/CFT073upaC. Total CFU were enumerated from the bladders of
infectedmice on selective medium to differentiate between E. coliCFT073amp/
CFT073upaB and E. coli CFT073amp/CFT073upaC. Each symbol represents
the Log10 fitness index calculated for each individual mouse, and themedian is
represented by a horizontal line. A Log10 fitness index below 0 (shown by the
dashed line) indicates that the upaB mutant is at a competitive disadvantage
(P  0.014). (B and C) Single-infection assay employing E. coli CFT073 and
CFT073upaB. Data for individual mice are expressed as the Log10 of total CFU
per 0.1 g of bladder tissue at day 1 (B) and day 5 (C) postinfection. The number
of mice used for each experiment (n) is indicated. The data represent a com-
pilation of the results from two individual experiments. Medians are indicated
by a solid line. E. coliCFT073 was recovered from the bladder of infected mice
at day 1 postinfection in significantly higher numbers than CFT073upaB (P
0.001). No statistical difference in the number of E. coli CFT073 and
CFT073upaB was observed at day 5 postinfection.
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In themurine UTImodel, UPEC colonization of the bladder is
associated with the formation of intracellular bacterial communi-
ties (IBCs) within superficial umbrella cells (2). IBCs possess
biofilm-like properties and are comprised of compact cell clusters
encased in a polysaccharide matrix. IBC formation creates a qui-
escent state that may be associated with long-term persistence in
the bladder (17, 47). Two phase-variable cell surface factors asso-
ciated with biofilm formation, type 1 fimbriae and Ag43, are ex-
pressed by UPEC within IBCs (2). We did not observe any evi-
dence of phase-variable expression of UpaB or UpaC. However,
given that UpaC promoted biofilm formation and UpaB pro-
moted adherence to several ECM proteins, it is possible that both
UpaB and UpaC contribute to this phenotype.
A number of AT proteins have now been shown to contribute
to UPEC virulence. Ag43, UpaB, and UpaH contribute to coloni-
zation of the mouse bladder, albeit at different stages of infection.
The UpaB and UpaG AT proteins mediate adherence to ECM
proteins, while UpaG is also associated with adherence to bladder
epithelial cells. In addition, the majority of these AT proteins are
associated with biofilm formation, with Ag43 also contributing to
IBC formation. The expression of these proteins may be coordi-
nated with other larger surface structures, such as the capsule, O
antigen, flagella, and fimbriae, tomediate their affect on the ability
of UPEC to colonize different niches.
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